Breaking News

Jubilant Biosys Adds Agilent’s RapidFire/MS Screening Platform

Becomes first facility in India to be equipped with the RapidFire Mass Spec technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jubilant Biosys has added Agilent Technologies’ RapidFire/MS screening technology to its drug discovery platform.   RapidFire is a solid phase extraction technology that enables label-free detection of native compounds by mass spectrometry in a wide range of in vitro assays, DMPK/ADME studies, hit/lead applications for drug discovery, as well as screening difficult targets that are not amenable to labeled assays. Jubilant’s Bengaluru facility will be the first in India to be equipp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters